Advocacy intelligence hub — real-time data for patient organizations
FINANCIAL LANDSCAPE SUMMARY
Total programs
Open now
Patient Assistance Programs1
Tecelra
USWM CT, LLC
Tecelra
(afamitresgene autoleucel)Orphan drugacceleratedUSWM CT, LLC
12.1 Mechanism of Action TECELRA is a genetically modified autologous T cell immunotherapy consisting of CD4 and CD8 positive T cells transduced with ...